Ardy Arianpour arrived in San Diego as a six year old immigrant from the Middle East and didn’t waste time getting going. By 16 he was working at the Salk Institute and after college pursued a series of sales and marketing roles, even finding time to get involved in a landmark gene patent lawsuit at the US Supreme Court.
As co-founder and CEO of Seqster, he’s bringing person-centric interoperability to the masses. Seqster has the wind at its back. And with the 21st Century Cures Act, Ardy contends that Seqster essentially is the law.
In this episode of the HealthBiz podcast, Ardy explains what it means to be a data artist, how to be patient centric when your customers are not the patients, and why Seqster is different from everything else out there. He also digs in to the reasons behind Takeda’s investment in the company and the recent partnerships with Medable and Datavant.